Widely used:Recently Viewed
Clear AllValue Research Rating
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
₹5,361 Cr
Revenue (TTM)
₹687 Cr
Net Profit (TTM)
₹92 Cr
ROE
13.2 %
ROCE
18.8 %
P/E Ratio
58.6
P/B Ratio
9.8
Industry P/E
58.58
EV/EBITDA
25.9
Div. Yield
2.1 %
Debt to Equity
0
Book Value
₹103.2
EPS
₹17.3
Face value
10
Shares outstanding
52,994,447
CFO
₹1,092.14 Cr
EBITDA
₹1,422.91 Cr
Net Profit
₹828.64 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Thyrocare Tech
| 10.3 | 26.5 | 38.6 | 60.4 | 14.5 | 13.7 | -- |
|
BSE Healthcare
| -5.9 | 0.5 | 7.3 | 18.6 | 22.8 | 22.3 | 9.5 |
|
BSE Small Cap
| -6.0 | 4.8 | 12.4 | 7.4 | 25.0 | 37.4 | 16.5 |
|
Company
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|---|---|---|---|---|---|---|---|
|
Thyrocare Tech
| 39.8 | 4.0 | -44.1 | 18.1 | 69.2 | 1.9 | -22.7 |
|
BSE Small Cap
| 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 | -23.4 |
|
BSE Healthcare
| 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 | -5.9 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Thyrocare Tech
|
1,005.7 | 5,360.7 | 687.4 | 92.3 | 19.7 | 17.7 | 58.6 | 9.8 |
| 2,849.8 | 23,806.9 | 2,461.4 | 492.2 | 22.5 | 23.3 | 48.9 | 11.0 | |
| 1,219.9 | 32,752.4 | 3,692.3 | 481.3 | 18.5 | 15.9 | 68 | 9.7 | |
| 1,459.3 | 9,564.4 | 1,257.1 | 193.5 | 18.7 | 14.8 | 49.5 | 7.1 | |
| 672.9 | 26,955.4 | 3,035.0 | 414.5 | 19.9 | 18.2 | 70.1 | 12.6 | |
| 641.4 | 2,071.6 | 717.2 | 77.6 | 14.2 | 9 | 26.7 | 2.3 | |
| 39.3 | 39.2 | 9.8 | 1.9 | 29.0 | -- | 20.7 | -32.6 | |
| 1,626.3 | 8,421.4 | 1,331.2 | 145.5 | 14.6 | 11.5 | 58.1 | 6.3 | |
| 911.0 | 9,369.7 | 681.4 | 143.8 | 29.7 | 18.9 | 65.5 | 11.8 |
Best of both worlds: profits and dividends
4 min read•By Danish Khanna
2 min read•By Jugal Harpalani
Two unloved stocks to watch out for
4 min read•By Danish Khanna
Thyrocare Technologies Limited provides diagnostic testing services to patients, laboratories, and hospitals in India. It operates through three segments: Diagnostic Testing Services, Imaging Services, and Others. The company conducts various medical... diagnostic tests and profiles of tests that focuses on early detection and management of disorders and diseases, including thyroid, growth, metabolism, auto-immunity, diabetes, anaemia, cardiovascular, infertility, and various infectious diseases. Its profiles of tests include profiles of tests administered under its Aarogyam brand, which offers patients a suite of wellness and preventive health care tests. The company sells glucometer and glucostrips under the brand name Sugarscan; consumables; and radiopharmaceutical products. Thyrocare Technologies Limited was founded in 1996 and is based in Navi Mumbai, India. Thyrocare Technologies Limited is a subsidiary of Docon Technologies Private Limited. Read more
Incorporated
2000
Chairman
--
Managing Director
Rahul Guha
Group
MNC
Headquarters
Navi Mumbai, Maharashtra
Website
Looking for more details about Thyrocare Technologies Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Thyrocare Technologies Ltd stood at ₹ 693 Cr as on 31-Mar-25
The share price of Thyrocare Technologies Ltd is ₹1,005.70 (NSE) and ₹1,011.55 (BSE) as of 23-May-2025 IST. Thyrocare Technologies Ltd has given a return of 14.46% in the last 3 years.
Thyrocare Technologies Ltd has a market capitalisation of ₹ 5,361 Cr as on 23-May-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Thyrocare Technologies Ltd is 9.80 times as on 23-May-2025, a 0% premium to its peers’ median range of 9.80 times.
The P/E ratio of Thyrocare Technologies Ltd is 58.58 times as on 23-May-2025, a 0% premium to its peers’ median range of 58.58 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Thyrocare Technologies Ltd and enter the required number of quantities and click on buy to purchase the shares of Thyrocare Technologies Ltd.
Thyrocare Technologies Limited provides diagnostic testing services to patients, laboratories, and hospitals in India. It operates through three segments: Diagnostic Testing Services, Imaging Services, and Others. The company conducts various medical diagnostic tests and profiles of tests that focuses on early detection and management of disorders and diseases, including thyroid, growth, metabolism, auto-immunity, diabetes, anaemia, cardiovascular, infertility, and various infectious diseases. Its profiles of tests include profiles of tests administered under its Aarogyam brand, which offers patients a suite of wellness and preventive health care tests. The company sells glucometer and glucostrips under the brand name Sugarscan; consumables; and radiopharmaceutical products. Thyrocare Technologies Limited was founded in 1996 and is based in Navi Mumbai, India. Thyrocare Technologies Limited is a subsidiary of Docon Technologies Private Limited.
The promoter of Thyrocare Technologies Ltd is Docon Technologies Private Limited. Docon Technologies Private Limited owns 71.06 per cent of the total equity. The chairman of the company is , and the managing director is Rahul Guha..
The promoters of Thyrocare Technologies Ltd have pledged 71.06% of the total equity as on Mar-25.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
9,370
|
|
|
8,421
|
|
|
2,072
|
|
|
39
|
|
|
32,752
|
|
|
26,955
|
|
|
23,807
|
|
|
9,564
|
|
|
9,370
|
| Thyrocare Technologies Ltd. | Ratios |
|---|---|
|
Return on equity(%)
|
17.71
|
|
Operating margin(%)
|
19.66
|
|
Net Margin(%)
|
13.15
|
|
Dividend yield(%)
|
2.08
|
Yes, TTM profit after tax of Thyrocare Technologies Ltd was ₹92 Cr.
₹43.35
(
